Anti-CD14 Treatment and Mortality in Severe COVID-19: A Secondary Subgroup Analysis by Baseline Plasma Presepsin Levels in the I-SPY COVID Adaptive Platform Trial
A23. INVESTIGATING HETEROGENEITY IN SEPSIS AND PNEUMONIA: TRIALS, COHORTS, AND PATIENT-ORIENTED RESEARCH（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要